Heart Failure POC and LOC Devices Market

• Growing demand for POC & LOC devices is anticipated to fuel the market growth

Lab-on-chip (LOC) is used to accelerate disease diagnosis due to factors including simplicity of use, speed of results, and high throughput. POC helps identify cardiac indicators and time-critical elements so that medical problems can be handled more successfully. The need for POC and LOC devices is driven by worries about mobility and mortality due to cardiovascular disease. The number of POC tests aimed at different biomarkers has expanded, and various private and public sectors have increased their spending in creating cutting-edge POC and LOC devices, leading to increased market demand.

Leading businesses are also anticipated to expand their spending on improved goods and incorporate smartphones, apps, and POC detection for controlling patient heart health in the upcoming years. For instance, the accuracy of HF diagnosis, severity estimate, and adverse event prediction has increased thanks to blood tests that measure biomarkers. The importance of biomarkers in managing HF is increased because they may be quickly assessed at the point of care. This has been made possible by creating mobile analytical devices, also called point-of-care testing (POCT) devices, which benefit from developments in microfluidics and nanotechnology.

Increasing LOC device usage is anticipated to fuel market expansion over the forecast period.

The heart failure POC & LOC device market is anticipated to be largely driven by the rise in CVDs.POC devices assist in measuring particular cardiac indicators like troponin, but LOC technology can potentially improve disease diagnosis. Heart disease was the main cause of death worldwide in December 2020, accounting for around one-third of fatalities in 2019, and this trend is predicted to continue. In 2019, China had the most heart disease fatalities, followed by India, Russia, the US, and Indonesia.

Additionally, according to a CDC report from 2018, approximately 655,000 Americans pass away from heart disease each year, making it the leading cause of death in the US (1 in every 4 deaths). In order to improve the management of data for patients with CVD, several large companies are competing to release high-quality devices and accessories. The growing patient population has eventually increased the demand for POC and LOC devices, which will continue to drive the market's CAGR.

Furthermore, there is a need for substantial R&D to discover more effective treatments and diagnostic techniques to stop the rapid rise of CVD problems as the worldwide burden of CVD rises. Point-of-care testing (POCT), a crucial technology for diagnosing CVDs such as heart failure, will drive the market for heart failure POC & LOC devices in the future. This is due to the growth in R&D investments for heart and CVD.

An investment of USD 190 million will be committed over the next ten years for heart disease-related research, according to a study released by the government of New South Wales in June 2018. Furthermore, NIH funding for cardiovascular diseases increased from USD 1,964 million in 2013 to an estimated USD 2,496 million in 2020. Therefore, such an increase in funding will eventually support the heart failure POC & LOC devices market revenue.

The Global Heart Failure POC and LOC Devices Market Industry is projected to experience substantial growth over the next decade. With a market valuation of 0.07 USD Billion in 2024, it is anticipated to reach 0.36 USD Billion by 2035. This growth trajectory suggests a CAGR of 16.09% from 2025 to 2035, driven by factors such as technological advancements, increased healthcare investments, and rising awareness of heart failure management. These projections indicate a robust future for the industry, emphasizing the importance of ongoing innovation and adaptation to meet the evolving needs of patients and healthcare providers.

The increasing incidence of heart failure globally is a primary driver for the Global Heart Failure POC and LOC Devices Market Industry. As populations age and lifestyle-related diseases become more prevalent, the demand for effective monitoring and management solutions rises. In 2024, the market is valued at 0.07 USD Billion, reflecting the urgent need for innovative devices that can assist in early detection and ongoing management of heart failure. This trend is expected to continue, with projections indicating a market growth to 0.36 USD Billion by 2035, highlighting the critical role of POC and LOC devices in addressing this growing health concern.

The shift towards preventive healthcare is reshaping the Global Heart Failure POC and LOC Devices Market Industry. Healthcare systems worldwide are increasingly emphasizing early detection and management of chronic diseases, including heart failure. This focus is driving demand for point-of-care and lab-on-a-chip devices that allow for timely interventions and better patient management. As healthcare providers seek to reduce hospital admissions and improve patient quality of life, the market is expected to expand significantly. The anticipated growth trajectory suggests that the market will evolve to meet these preventive healthcare needs, further solidifying the role of innovative devices in heart failure management.

Advancements in technology are significantly influencing the Global Heart Failure POC and LOC Devices Market Industry. Innovations such as miniaturization, enhanced connectivity, and improved sensor technology are enabling the development of more efficient and user-friendly devices. These advancements not only improve patient outcomes but also facilitate remote monitoring, which is increasingly important in managing chronic conditions like heart failure. As a result, the market is poised for substantial growth, with a projected CAGR of 16.09% from 2025 to 2035, indicating a robust future driven by continuous innovation in device design and functionality.

Investment in healthcare infrastructure is a crucial driver for the Global Heart Failure POC and LOC Devices Market Industry. Governments and private entities are increasingly allocating resources to enhance healthcare facilities and improve access to advanced medical technologies. This trend is particularly evident in developing regions, where the establishment of modern healthcare systems is essential for managing chronic diseases like heart failure. As healthcare infrastructure improves, the adoption of POC and LOC devices is likely to increase, facilitating better patient outcomes and contributing to the overall growth of the market. The ongoing investments indicate a promising future for the industry.

Increasing awareness and education regarding heart failure are pivotal in driving the Global Heart Failure POC and LOC Devices Market Industry. Public health campaigns and educational initiatives are informing patients and healthcare providers about the importance of early detection and management of heart failure. This heightened awareness is leading to greater acceptance and utilization of POC and LOC devices, as patients seek to actively participate in their health management. As awareness continues to grow, the market is expected to expand, reflecting the critical role of education in promoting the adoption of innovative heart failure management solutions.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American heart failure POC & LOC devices market area will dominate this market since it generates a sizable organic revenue share as a result of significant competitor involvement. The market expansion in the region is primarily driven by early acceptance of cutting-edge medical technology and increased development of new technologies from important regional companies for the development of heart failure treatment devices.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: HEART FAILURE POC & LOC DEVICES MARKET SHARE BY REGION 2022 (%) 

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe heart failure POC & LOC devices market accounts for the second-largest market share as a result of factors including increased cardiovascular disease prevalence, a sophisticated and well-equipped healthcare infrastructure, the existence of major players, and rising microfluidics technology adoption. Further, the German heart failure POC & LOC devices market held the largest market share, and the UK heart failure POC & LOC devices market was the fastest growing market in the European region

The Asia-Pacific Heart failure POC & LOC devices Market is expected to grow at the fastest CAGR from 2023 to 2032 due to the region's modern infrastructure development and growing medical practice standards. Additionally, the regional market has grown as a result of major players shifting their investments from infectious to chronic diseases like cardiac ischemia, myocardial infarction, and acute coronary syndrome. Moreover, China’s heart failure POC & LOC devices market held the largest market share, and the Indian heart failure POC & LOC devices market was the fastest growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the heart failure POC & LOC devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, heart failure POC & LOC devices industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the heart failure POC & LOC devices industry to benefit clients and increase the market sector. In recent years, the heart failure POC & LOC devices industry has offered some of the most significant advantages to medicine. Major players in the heart failure POC & LOC devices market attempting to increase market demand by investing in research and development operations include Abbott (US), F.

Hoffmann-La Roche Ltd. (Switzerland), Danaher (US), Abaxis, Inc. (US), Quidel Corporation (US), Siemens Healthineers (Germany), JantPharmacal Corporation (US), Trinity Biotech (Ireland), bioMérieux S.A (France), and Instrumentation Laboratory Company (US).

A division of Siemens AG, Siemens Healthineers AG (Siemens Healthineers) is a manufacturer and distributor of diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive treatments. The company's key products include mobile C-arms, hybrid operating rooms, angiography systems, ultrasound systems, computed tomography systems, magnetic resonance imaging systems, testing systems, and point-of-care (POC) testing systems. In April 2021, the AtellicaVTLi Patient-Side Immunoassay Analyzer from Siemens Healthineers has acquired CE mark clearance and can be used as a point-of-care diagnostic to help diagnose heart attacks.

Abaxis Inc. (Abaxis) is a provider of technology, tools, and services for a variety of medical applications for the care of patients in both human and veterinary settings. The company's primary areas of interest include developing, producing, and marketing portable blood analysis systems. Its portfolio includes patented goods like chemistry analyzers, reagent discs, blood gas and immunoassays, haematology analyzers and reagent rotors. Multiple tests are run on blood, serum, or plasma using the Abaxis laboratory system. The company distributes goods in the US through a network of independent distributors in the Asia, Americas, Europe, the Middle East, and Africa.